Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
about
Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed.Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.5-Hydroxy-4'-Nitro-7-Propionyloxy-Genistein Inhibited Invasion and Metastasis via Inactivating Wnt/b-Catenin Signal Pathway in Human Endometrial Carcinoma Ji Endometrial Cells.
P2860
Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Expression of p53, p16, cyclin ...... bone squamous cell carcinoma.
@en
type
label
Expression of p53, p16, cyclin ...... bone squamous cell carcinoma.
@en
prefLabel
Expression of p53, p16, cyclin ...... bone squamous cell carcinoma.
@en
P2093
P2860
P1476
Expression of p53, p16, cyclin ...... bone squamous cell carcinoma.
@en
P2093
Akihiro Homma
Atsushi Fukuda
Hiromitsu Hatakeyama
Satoshi Fukuda
Satoshi Kano
Shinichiro Yasukawa
Shinya Morita
Tomohiro Sakashita
Yuji Nakamaru
P2860
P2888
P304
P356
10.1007/S10147-016-1026-5
P577
2016-08-03T00:00:00Z